
Gilead Sciences (GILD): Future Prospects and Stock Price Outlook
Gilead Sciences (GILD) is a biopharmaceutical company that develops and markets HIV and cancer drugs and offers a strong financial position and high dividends. We take a closer look at the company's business and growth potential.